City
Epaper

Covid vaccination plan ambitious yet realistic, says DST's Dr Ashutosh Sharma

By ANI | Published: May 31, 2021 11:04 AM

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

Open in App

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

"In terms of technology, we are totally prepared for the third wave and would get even better as we go forward this year. Our vaccination plan to innoculate all citizens of the country by December is not only ambitious but also realistic," Dr Sharma toldon Sunday.

"During the first wave, we built a huge infrastructure which was related to basic things like ventilator, all kinds of diagnostics, PPE kits, N-95 masks, now we even have a vaccine which is of Indian origin. In addition to setting up the infrastructure for vaccine, cold chain, the supply lines, logistics, all have been put together quickly in the first wave," Dr Sharma said.

He added, "the second wave was rather sudden and we found that certain things were missing and that was not as much available in quantity as was needed at the peak of the second wave."

Speaking about the innovation related to oxygen supply, he said many innovations have been done related to the oxygen supply like repurposing many oxygen plants where plants that were producing industrial oxygen have been repurposed for the medical oxygen.

As India battles the second wave of the coronavirus pandemic science-based start-ups and innovations are playing a crucial role.

Speaking on innovation related to RT-PCR testing, the doctor said that new RT-PCR from Sree Chitra Tirunal Institute for Medical Sciences and Technology targets two genes, one of which does not undergo many mutations. "So, we will not produce false RT-PCR readings as much as otherwise might happen."

"An antibody kit has been developed at Indian Institute of Science, Bangalore. lt looks at antibodies IgM and IgG. The kit measures the quantity of antibodies. It also determines if they are fading." Dr Sharma added.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiabangaloreSree Chitra Tirunal Institute For Medical Sciences And TechnologyDepartment of science and technologyNodal departmentIndiUk-indiaScience and innovation blade nzimandeRepublic of indiaDepartment of science and technology of india
Open in App

Related Stories

NationalLok Sabha Election Results 2024: I.N.D.I.A Bloc Govt Is Going To Be Formed on June 4, Says Rahul Gandhi

NationalLok Sabha Election 2024: I.N.D.I.A Bloc To Get Decisive Mandate Due to Positive Campaign, Says Jairam Ramesh

InternationalChina Deploys J-20 Stealth Fighters Near India’s LAC Amid Ongoing Tensions

NationalHeatwave in Bihar: 19 Dead in 24 Hours as Temperatures Soar Above 45°C, Alert Issued for Next Two Days

TechnologyWomen Hiring for Leadership Roles in India Rises to 23.2% in Early 2024: LinkedIn Report

National Realted Stories

NationalFree from campaigning, MP CM to take the rural route to review governance

NationalCertificates from accredited driver training schools don’t exempt from driving test requirements: Centre

NationalTejashwi Yadav Spotted Limping During INDIA Bloc Meeting Ahead of Lok Sabha Election Results 2024 (Watch Video)

NationalTension erupts in Odisha's Salipur over booth capturing allegations

NationalAbduction case: SIT reaches home of arrested JD(S) MP's mother Bhavani; awaits her arrival